An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes-Reference-Cited by-同舟云学术

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Published:2018-09-06 Issue:1 Volume:126 Page:5-18
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J Neural Transm

Author:

Mostafa Sam^ORCID,Kirkpatrick Carl M. J.,Byron Keith,Sheffield Leslie

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00702-018-1922-0/fulltext.html

Reference55 articles.

1. Bank PCD, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, Relling MV, Guchelaar HJ (2018) Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group. Clin Pharmacol Ther 103:599–618. https://doi.org/10.1002/cpt.762

2. Benedetti MS (2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 14:301–319

3. Borges S, Desta Z, Jin Y, Faouzi A, Robarge JD, Philips S, Nguyen A, Stearns V, Hayes D, Rae JM, Skaar TC, Flockhart DA, Li L (2010) Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients. J Clin Pharmacol 50:450–458. https://doi.org/10.1177/0091270009359182

4. Caudle KE, Rettie AE, Whirl-Carrillo M, Smith LH, Mintzer S, Lee MT, Klein TE, Callaghan JT, Clinical Pharmacogenetics Implementation C (2014) Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. Clin Pharmacol Ther 96:542–548. https://doi.org/10.1038/clpt.2014.159

5. Cespedes-Garro C, Fricke-Galindo I, Naranjo ME, Rodrigues-Soares F, Farinas H, de Andres F, Lopez-Lopez M, Penas-Lledo EM, LLerena A (2015) Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. Expert Opin Drug Metab Toxicol 11:1893–1905. https://doi.org/10.1517/17425255.2015.1111871

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers;Clinical Pharmacology & Therapeutics;2024-07-29

3. Pharmacogenomics: The Promising Future of Clinical Therapeutics;J BIOL REG HOMEOS AG;2024

4. The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics;Pharmacopsychiatry;2024-02-14

5. Pharmacogenomics – a minor rather than major force in clinical medicine;Expert Review of Clinical Pharmacology;2024-02-06